UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.559

Sortiert nach

Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia

Journal of neurology, 2012-05, Vol.259 (5), p.851-854

2012

Volltextzugriff (PDF)

Charles Bonnet syndrome in a young patient with a history of epilepsy

Neurología (Barcelona, English ed. ), 2019-09, Vol.34 (7), p.488-490

2019

Volltextzugriff (PDF)

Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study)

Journal of neurology, 2010-09, Vol.257 (9), p.1500-1507

2010

Volltextzugriff (PDF)

Four new cases of therapy-related acute promyelocytic leukemia after mitoxantrone

Neurology, 2008-08, Vol.71 (6), p.457

2008

Volltextzugriff (PDF)

Tako-tsubo cardiomyopathy and status epilepticus: a case report

European journal of neurology, 2008-05, Vol.15 (5), p.e34-e35

2008

Volltextzugriff (PDF)

Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study

Journal of neurology, 2018-07, Vol.265 (7), p.1690-1697

2018

Volltextzugriff (PDF)

Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands

Multiple sclerosis, 2010-07, Vol.16 (7), p.810-815

2010

Volltextzugriff (PDF)

Functional magnetic resonance imaging correlates of cognitive performance in patients with a clinically isolated syndrome suggestive of multiple sclerosis at presentation: an activation and connectivity study

Multiple sclerosis, 2012-02, Vol.18 (2), p.153-163

2012

Volltextzugriff (PDF)

Effect of relapses over early progression of disability in multiple sclerosis patients treated with beta-interferon

Multiple sclerosis, 2008-06, Vol.14 (5), p.636-639

2008

Volltextzugriff (PDF)

Analysis of “task-positive” and “task-negative” functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis

Experimental brain research, 2013-03, Vol.225 (3), p.399-407

2013

Volltextzugriff (PDF)

No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis

Neuroscience letters, 2006-04, Vol.396 (3), p.217-219

2006

Volltextzugriff (PDF)

The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands

Journal of neuroimmunology, 2010-09, Vol.226 (1), p.143-146

2010

Volltextzugriff (PDF)

Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis

Neurology, 2007-07, Vol.69 (1), p.63

2007

Volltextzugriff (PDF)

Study of the relationship between white matter lesions in the magnetic resonance imaging and patent foramen ovale

Neurología (Barcelona, Spain), 2008-10, Vol.23 (8), p.499-502

2008

Volltextzugriff (PDF)

Early abnormalities in evoked potentials and future disability in patients with multiple sclerosis

Multiple sclerosis, 2006-08, Vol.12 (4), p.521-522

2006

Volltextzugriff (PDF)

Síndrome de Charles Bonnet en paciente joven con antecedentes de epilepsia

Neurología (Barcelona, Spain), 2019-09, Vol.34 (7), p.488-490

2019

Volltextzugriff (PDF)

Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data

Neurología (Barcelona, Spain), 2008-03, Vol.23 (2), p.73

2008

Volltextzugriff (PDF)

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis

Neurologia (Barcelona, Spain), 2014-06, Vol.29 (5), p.257

2014

Volltextzugriff (PDF)

Evaluation of response of multiple sclerosis (MS) relapse to oral high-dose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale

European journal of neurology, 2008-03, Vol.15 (3), p.284-288

2008

Volltextzugriff (PDF)

Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer

BMC cancer, 2013-02, Vol.13 (1), p.87-87, Article 87

2013

Volltextzugriff (PDF)

CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis

European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A99-A99

2017

Volltextzugriff (PDF)

Neurologic manifestations of Behcet disease: description of 15 patients in Valencia (Spain)

Multiple sclerosis, 2008-09, Vol.14, p.S239-S239

2008

Volltextzugriff (PDF)

Short term validity of Barkhof and Swanton magnetic resonance imaging criteria for multiple sclerosis in patients with clinically isolated syndromes

Multiple sclerosis, 2008-09, Vol.14, p.S113-S113

2008

Volltextzugriff (PDF)

Assessment of heterogeneity in meta-analysis

Cirugia española (English ed.), 2024-04

2024

Volltextzugriff (PDF)

Compromise of the cognitive functions in progressive secondary multiple sclerosis

Revista de neurologiá, 2008-06, Vol.46 (11), p.664-666

2008

Volltextzugriff (PDF)

1 – 25 von 1.559

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.256)
Mit Volltextzugriff
(1.422)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(42)

Menü

Weitere Dienste

Einstellungen

Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia

Charles Bonnet syndrome in a young patient with a history of epilepsy

Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study)

Four new cases of therapy-related acute promyelocytic leukemia after mitoxantrone

Tako-tsubo cardiomyopathy and status epilepticus: a case report

Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study

Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands

Functional magnetic resonance imaging correlates of cognitive performance in patients with a clinically isolated syndrome suggestive of multiple sclerosis at presentation: an activation and connectivity study

Effect of relapses over early progression of disability in multiple sclerosis patients treated with beta-interferon

Analysis of “task-positive” and “task-negative” functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis

No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis

The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands

Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis

Study of the relationship between white matter lesions in the magnetic resonance imaging and patent foramen ovale

Early abnormalities in evoked potentials and future disability in patients with multiple sclerosis

Síndrome de Charles Bonnet en paciente joven con antecedentes de epilepsia

Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis

Evaluation of response of multiple sclerosis (MS) relapse to oral high-dose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale

Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer

CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis

Neurologic manifestations of Behcet disease: description of 15 patients in Valencia (Spain)

Short term validity of Barkhof and Swanton magnetic resonance imaging criteria for multiple sclerosis in patients with clinically isolated syndromes

Assessment of heterogeneity in meta-analysis

Compromise of the cognitive functions in progressive secondary multiple sclerosis

Suchergebnisse filtern